Extranodal NK-T-cell lymphoma future or investigational therapies: Difference between revisions
No edit summary |
No edit summary |
||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
High dose chemotherapy and [[autologous]] [[haematopoietic]] [[stem cell transplantation]] is used for varying types of [[lymphoma]], however there is a lac of such experience in treating extranodal NK-T cell lymphoma. Further clinical trials are needed to prove that this therapy is handy and can be used as a method of therapy. [[Autologous]] [[transplantation]] appears to provide a great survival benefit only for those who attended a complete remission at the time of transplantation. | |||
==Future or Investigational Therapies== | ==Future or Investigational Therapies== | ||
High dose chemotherapy and [[autologous]] [[haematopoietic]] [[stem cell transplantation]] is used for varying types of [[lymphoma]], however there is a lac of such experience in treating extranodal NK-T cell lymphoma.<ref name="Liang2009">{{cite journal|last1=Liang|first1=Raymond|title=Advances in the management and monitoring of extranodal NK/T-cell lymphoma, nasal type|journal=British Journal of Haematology|volume=147|issue=1|year=2009|pages=13–21|issn=00071048|doi=10.1111/j.1365-2141.2009.07802.x}}</ref> Further clinical trials are needed to prove that this therapy is handy and can be used as a method of therapy. [[Autologous]] [[transplantation]] appears to provide a great survival benefit only for those who attended a complete remission at the time of transplantation. | |||
==References== | ==References== |
Latest revision as of 13:28, 3 September 2019
Xyz Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Extranodal NK-T-cell lymphoma future or investigational therapies On the Web |
American Roentgen Ray Society Images of Extranodal NK-T-cell lymphoma future or investigational therapies |
FDA on Extranodal NK-T-cell lymphoma future or investigational therapies |
CDC on Extranodal NK-T-cell lymphoma future or investigational therapies |
Extranodal NK-T-cell lymphoma future or investigational therapies in the news |
Blogs on Extranodal NK-T-cell lymphoma future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ramyar Ghandriz MD[2]
Overview
High dose chemotherapy and autologous haematopoietic stem cell transplantation is used for varying types of lymphoma, however there is a lac of such experience in treating extranodal NK-T cell lymphoma. Further clinical trials are needed to prove that this therapy is handy and can be used as a method of therapy. Autologous transplantation appears to provide a great survival benefit only for those who attended a complete remission at the time of transplantation.
Future or Investigational Therapies
High dose chemotherapy and autologous haematopoietic stem cell transplantation is used for varying types of lymphoma, however there is a lac of such experience in treating extranodal NK-T cell lymphoma.[1] Further clinical trials are needed to prove that this therapy is handy and can be used as a method of therapy. Autologous transplantation appears to provide a great survival benefit only for those who attended a complete remission at the time of transplantation.
References
- ↑ Liang, Raymond (2009). "Advances in the management and monitoring of extranodal NK/T-cell lymphoma, nasal type". British Journal of Haematology. 147 (1): 13–21. doi:10.1111/j.1365-2141.2009.07802.x. ISSN 0007-1048.